A Distinct Expression of Various Gene Subsets in CD34+Cells Obtained From Patients with Early and Advanced Myelodysplastic Syndrome

被引：0
作者：
Belickova, Monika [1 ]
Cermak, Jaroslav [1 ]
Vasikova, Alzbeta [1 ]
Budinska, Eva [2 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic
[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1459 / 1460
页数：2
相关论文
共 50 条
  • [21] Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
    Baumeister, Julian
    Maie, Tiago
    Chatain, Nicolas
    Gan, Lin
    Weinbergerova, Barbora
    de Toledo, Marcelo A. S.
    Eschweiler, Joerg
    Maurer, Angela
    Mayer, Jiri
    Kubesova, Blanka
    Racil, Zdenek
    Schuppert, Andreas
    Costa, Ivan
    Koschmieder, Steffen
    Brummendorf, Tim H.
    Gezer, Deniz
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 2943 - 2956
  • [22] Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome
    Wolf C. Prall
    Akos Czibere
    Franck Grall
    Dimitrios Spentzos
    Ulrich Steidl
    Aristoteles Achilles Nikolaus Giagounidis
    Andrea Kuendgen
    Hasan Otu
    Astrid Rong
    Towia A. Libermann
    Ulrich Germing
    Norbert Gattermann
    Rainer Haas
    Manuel Aivado
    International Journal of Hematology, 2009, 89 : 173 - 187
  • [23] Relative distribution of different compartments of CD34+cells in the bone marrow of patients with myelodysplastic syndromes
    Matarraz, S.
    Lopez, A.
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Orfao, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 233 - 233
  • [24] Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
    Hofmann, WK
    de Vos, S
    Komor, M
    Hoelzer, D
    Wachsman, W
    Koeffler, HP
    BLOOD, 2002, 100 (10) : 3553 - 3560
  • [25] Phenotypic aberrations of myeloid CD34+cells in patients with myelodysplastic syndrome (MDS):: Clinical significance and correlation with cytogenetics abnormalities.
    Subira, D
    Font, P
    Arranz, E
    Ramiro, S
    Castanon, S
    Renedo, M
    Blas, C
    Garcia, MF
    Gonzalez, O
    Tomas, JF
    Fernandez-Rañada, JM
    BLOOD, 2004, 104 (11) : 652A - 652A
  • [26] Towards the lentiviral gene therapy of mobilized CD34+Cells from Fanconi anemia patients
    Bueren, Juan A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A12 - A12
  • [27] Gene expression during differentiation of cord-blood Cd34+cells to eosinophils
    Hashida, R
    Ogawa, K
    Miyagawa, M
    Sugita, Y
    Matsumoto, K
    Akasawa, A
    Saito, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S32 - S33
  • [28] Effects of Rigosertib (RIGO) Alone or in Combination with Azacitidine or Vorinostat on Epigenetic Reprogramming of CD34+Cells in the Myelodysplastic Syndrome
    Silverman, Lewis R.
    Chaurasia, Pratima
    Melana, Stella
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Navada, Shyamala C.
    Reddy, E. Premkumar
    BLOOD, 2017, 130
  • [29] Transcriptomic Evaluation of CD34+Marrow Cells from Myelodysplastic Syndrome (MDS) Patients
    Im, Hogune
    Rao, Varsha
    Sridhar, Kunju Joshi
    Chen, Rui
    Mias, George
    Zhang, Yan
    Xiao, Li
    Snyder, Michael P.
    Greenberg, Peter L.
    BLOOD, 2014, 124 (21)
  • [30] Karyotypic abnormalities in myelodysplastic syndrome do not correlate with increased number of CD34+cells in the bone marrow.
    Machhi, J
    van Tuinen, P
    Chang, C
    Shidham, VB
    Path, MRC
    Eshoa, C
    Kampalath, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 650 - 651
12345